Antidote Availability

Antidote Availability is a public health metric that denotes the extent to which specific pharmacological countermeasures for toxic exposures are accessible in timely, geographically distributed, and clinically appropriate settings.

44

Publications

1.3K

Citations

139

Authors

101

Institutions

Publications per year

2017–2026

3

Authors

139

  1. RC
    Richard C. Dart

    University of Colorado Denver, United States

    3 publications · 229 citations

    3

    h-index

  2. JB
    Jean‐François Bussières

    Centre Hospitalier Universitaire Sainte-Justine, Canada

    2 publications · 29 citations

    2

    h-index

  3. BB
    Benoît Bailey

    Centre Hospitalier Universitaire Sainte-Justine, Canada

    2 publications · 29 citations

    2

    h-index

  4. JR
    Jeffrey R. Brubacher

    University of British Columbia, Canada

    2 publications · 42 citations

    2

    h-index

  5. RP
    Roy Purssell

    University of British Columbia, Canada

    2 publications · 42 citations

    2

    h-index

1–5 of 139

Venues

  1. PubMed

    Repository · 6 publications · 119 citations

    6

    h-index

  2. American Journal of Health-System Pharmacy

    AJHP · 4 publications · 83 citations

    4

    h-index

  3. Toxicon

    3 publications · 216 citations

    3

    h-index

  4. JAMA

    2 publications · 103 citations

    2

    h-index

  5. Annals of Emergency Medicine

    2 publications · 153 citations

    2

    h-index

1–5